Brochure | March 9, 2026

Gen2 Digital Validation Platform: End-To-End Digital Validation

Source: CAI
GettyImages-2200522087-computer-digital-validation-hand-with-pen

Digital validation is shifting rapidly, and organizations in pharma and biotech are under increasing pressure to streamline their qualification and compliance workflows. Discover an end‑to‑end digital validation platform that is designed to sharply reduce manual effort while improving accuracy and traceability. Learn how AI‑generated test scripts, automated trace matrices, and reusable master data libraries can shrink validation timelines from months to weeks while maintaining alignment with 21 CFR Part 11 and Annex 11 requirements. With reported gains of up to 85% time savings and more than 90% error reduction, find out how to modernize validation practices without heavy setup or per‑user licensing barriers.

Access the full brochure to get a clear look at a practical path toward true digital validation maturity.

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online